@article{c4a9d85fdcf7485aa3f82c4a82129e5b,
title = "Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group",
keywords = "Mantle cell lymphoma, elderly patients, immunochemotherapy, maintenance, rituximab, cytarabine, fludarabine, toxicity, outcome, PROGRESSION-FREE SURVIVAL, LATE-ONSET NEUTROPENIA, HIGH-DOSE THERAPY, STUDY-GROUP GLSG, MOLECULAR REMISSION, PROGNOSTIC INDEX, HYPER-CVAD, TRANSPLANTATION, CHEMOTHERAPY, IMPROVES, 3121 General medicine, internal medicine and other clinical medicine, 3122 Cancers",
author = "Riikka R{\"a}ty and Tuomo Honkanen and Esa Jantunen and Sirkku Jyrkkio and Marja-Liisa Karjalainen-Lindsberg and Outi Kuittinen and Minna Lehto and Maija Mikkola and Eira Poikonen and Auvo Rauhala and Johanna Rimpilainen and Anu Rasanen and Sanna Siitonen and Merja Suominen and Mirja Vapaatalo and Erkki Elonen",
year = "2012",
month = oct,
doi = "10.3109/10428194.2012.672736",
language = "English",
volume = "53",
pages = "1920--1928",
journal = "Leukemia & lymphoma",
issn = "1042-8194",
publisher = "Taylor & Francis",
number = "10",
}